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Carcinoma of the gallbladder is a relatively rare malignancy which is difficult to diagnose. The advent of
improved imaging methods and the expansion of interventional radiology however, combined with
advances in surgical technique, has produced a change in attitude towards this tumour. The available
world literature since 1960 has been reviewed and is presented in this article. However, whilst the
outlook for diagnosis and treatment is improving, clearly the association with cholelithiasis (between
45% and 100%), is a cause for concern particularly with the advent of treatments (lithotripsy,
percutaneous gallstone extraction) which leave gall bladder mucosa and residual fragments of stone in
situ.
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INTRODUCTION
Primary carcinoma of the gallbladder was first described by Maximilian Stoll in
1777 and is an uncommon neoplasm encountered in about 1% of cholecystectomy
operations and about 1% of autopsies in the United Kingdom1’2, but it is the most
common of the biliary tract malignancies resulting in approximately 6,500 deaths
per year in the USA. It predominantly affects women with a peak incidence in the
70 to 80 year old age group with female to male ratio of approximately 3-4:1,
although ratios as high as 8:1 have been reported3’ 4.
In the early stages of the disease symptoms are extremely uncommon and if they
do occur, are usually due to the co-existence of cholecystitis, cholelithiasis or
complications of associated benign biliary disease. Severe local or generalised
symptoms occur only when the disease is advanced and has spread beyond the
gallbladder. Sixteen percent of gallbladder carcinomas are found incidentally
during examination of the routine cholecystectomy specimens5.
Ninety eight percent of malignant tumours of the gallbladder are carcinomas and
they are generally classified (according to their histologic differentiation) into:
adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma and oat cell
carcinoma5. The means of spread of these carcinomas may be lymphatic, vascular,
intraperitoneal, neural, intraductal or by direct extension6. Prognosis is related to
the extent of the disease and consequently in 1976 a staging and grading system was
introduced by Nevin et al7. They suggested five stages: Stage I--intramucosal;
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Stage IIinvolvement of mucosa and muscularis; Stage IIIinvolvement of all
three layers; Stage IVinvolvement of all three layers and the cystic lymph node;
Stage Vinvolvement of liver. The histological grades were" Grade I (well
differentiated), Grade II (moderately differentiated) and Grade III (poorly differ-
entiated).
Despite recent advances in surgery of the liver and the biliary tract, there has
been no dramatic improvement in the prognosis of the primary carcinoma of the
gallbladder. Five year survival rates of 1.4 to 4.1% are generally reported8,
although in a recent review a five year survival of 12% was found9. This poor
outlook is mainly due to the lack of an effective means of pre-operative diagnosis
(despite the use of ultrasound, computerised tomography and magnetic resonance
imaging) although interventional radiological techniques such as arteriography
seem very promising in assessing the lesion after the diagnosis is suspected.
We have reviewed the available literature on this subject over the last 30 years
and in this article have described the main findings of the 42 major series4’6-47.
AETIOLOGICAL FACTORS
While the aetiology of carcinoma of the gallbladder remains obscure, it is likely that
more than one factor is important in the pathogenesis. The co-existence of these
conditions with gallbladder carcinoma and the risk of carcinoma transformation are
shown in Table 1. Review of the literature reveals that although cholelithiasis,
genetic factors, malignant transformation of benign neoplasms of the gallbladder,
congenital abnormalities, bacterial infections, occupation, xanthogranulomatous
cholecystitis, chronic inflammatory bowel disease and previous biliary surgery have
been all noted in association with carcinoma of the gallbladder, gallstones remain
the sole major known risk factor.
Cholelithiasis It is estimated that 10 to 20 percent of the adult population in
developed countries have gallstones with a higher prevalence in women, and obese
and elderly patients48. Although gallstones are found in 45 to 100% of patients with
gallbladder carcinoma (Table 2), autopsy studies have shown that the overall
incidence of carcinoma of the gallbladder in all patients with cholelithiasis (irres-
pective of age) is only 1 to 3 percent49. In an epidemiological study from Minnesota
where 2583 known patients with gallstones were followed for the development of
gastrointestinal malignancies, it was found that the risk for gallbladder carcinoma
was increased threefold, but the increase was only significant in men5. According
to Diehl, the risk of cancer developing among patients with untreated cholelithiasis
was estimated to be between 0.2 and 0.5 percent over a 20 year period. Diehl has
also shown a strong relationship between gallstone size and gallbladder carcinoma,
larger gallstones being associated with an increased risk of carcinoma; for stones of
2.0 to 2.9 cm in diameter, the odds ratio (versus stone size of < 1 cm) was 2.4,
whereas for stones of 3 cm or larger, the ratio was 10.152. Similar figures have been
presented by Lowenfels et al. according to whom, the relative risk for gallbladder
carcinoma in people with stones of > 3cm in diameter is 9.2 compared to stones of
< 1 cm53. In this study it was estimated that 30% of all gallbladder carcinomas are
associated with large (> 3 cm) stones and that the annual rate of gallstone growth
is 2 mm53. This is particularly relevant to selection criteria for extracorporeal
lithotripsy which at present is used for small stones. Gallbladder carcinoma isGALLBLADDER TUMOURS 279
Table Aeitiological factors
Relative
Associated risk of
finding gall-bladder
Factors (%) carcinoma References
1. Gallstones > 80 ’
3 only (5,50,51)
in men; 0.2-
0.5% (over 20
years in both
sexes)
Size of gallstones > 3 cm: < cm (52,53)
=10.1
Type of gallstones (5)
2. Genetic (50)
American Indians
-Black American women
-Swedish men and women
3. Congenital cysts ’
20 fold (54,55)
4. Familial anomalous pan- (56)
creatobiliary duct union
5. Adenoma 19 (57,58)
6. Adenomyomatosis (61)
7. Diffuse calcification 10-25 (62)
porcelain gallbladder)
8. Bacterial infections ’
6 fold (63)
9. Xanthogranulomatous 8.6 (65)
cholecystitis
10. Occupation (66)
(rubber industry)
11. Chronic inflammatory 13 (67)
bowel disease
12. Previous biliary (49)
surgery
usually associated with cholesterol type stones which are formed by precipitation
(not secondary to pre-existing stones or infection)5’46. Whilst the aetiological
relationship of gallstones to carcinoma of the gallbladder remains incompletely
understood, chronic irritation is believed to be the major promoting factor for
neoplastic transformation5.
Genetic factors There is an increased incidence of carcinoma of the gallbladder
in certain racial and ethnic groups. In a case control study gallstones were
associated with an increased risk for gallbladder carcinoma in American Indians
(men and women), black American women and Swedish men and women5.
Unusually high rates of gallbladder carcinoma are also found among Hispanic
Americans, possibly due to racial intermixture5.
Congenital anomalies Cystic dilatation of the biliary tree predisposes to extrahe-
patic bile duct carcinoma with a 2.5 percent incidence54. The incidence of carci-
noma in choledochal cysts is 20 times greater than the incidence of bile duct
carcinoma in the general population with adenocarcinoma being the most com-
monly found histological variety5. Anomalous pancreatic biliary duct union with-
out the presence of choledochal cyst has been recently reported to show an
increased association with gallbladder carcinoma56. In these cases it is suggested280 J.A. PARASKEVOPOULOS ETAL.
Table 2 Carcinoma of the gallbladder review of the world literature: 1960-1990
Mean
No of Age Cholelithiasis
References cases (years) M:F (%)
5 year
survival
(%)
(10) 47 63 1:3 4.25
(11) 70 67.9 1:3.4 54.3 1.43
(12) 132 61 1:3.5 89 2
(6) 151
(13) 76 1:2 90 4
(14) 52 65 1:2.5 60 0
(15) 78 1:5 90 2.6
(16) 105 61 1:3 90.47 6
(17) 45 65 1:2.7 82 0
(18) 43 63.2 1:2 90.6 2.6
(19) 59 1:3 84.2 1.6
(3) 390 65.5 1:8 83.8 3.2
(20) 57 69 1:2.6 54 1:5
(21) 72 70 1:2 80
(22) 28 67.1 1:4.6 89.3 7.1
(23) 117 67 1:3 69 1.7
)24) 22 64 1:3.5 77 4.5
(25) 181 70.5 1:4.5 88.4 1.6
(26) 82 63.8 1:3 74.6 5
(27) 100 49 1:2 45 2
(28) 68 69 1:4 70
(7) 66 80.3
(29) 108 1:4 83 6.4
(30) 45 62 1:2 82
(31) 75 62 1:5.25 98 1.6
(32) 328 45.01 1:2.6 100 1.8
(33) 48 71.7 1:1.8 66.6 12.5
(34) 67 63 1:2.4 57 5.9
(35) 100 68 1:1.4 26 10
(36) 110 72 1:3.2 70 2
(37) 100 65 1:3.34 78
(38) 69 68.2 1:1.76 60.4
(39) 20 74 1:2.3 70 5
(40) 112 65 1:3.5 92 4
(41) 287 70 1:3.7 78.4
(42) 315 50 1:2.5
(43) 131
(44) 134 67
(9) 49 63 1:3.45 93.5 12
(45) 53 65 1:4 66 4
(8) 68 72 1:2 76 0
(46) 94 80.5 1:2.9 60.6
(47) 21 75.9 1:4 85.7 4.76
Total 4375
that longstanding pancreaticocholedochal reflux in the presence of anomalous
ductal union causes inflammation in the biliary duct and induces epithelial
56 metaplasia
Benign gallbladder lesions These lesions are generally classified into epithelial
tumours (adenoma), mesenchymal tumours (fibroma, lipoma, haemangioma) andGALLBLADDER TUMOURS 281
pseudotumours (cholesterol polyps, inflammatory polyps, adenomyoma); adeno-
mas are classified as papillary, tubular or mixed57. According to Kozuka et al.
adenomatous components are present in all the in situ carcinomas and 19 percent of
invasive carcinomas and he suggests that carcinomas may arise directly from these
adenomata58. There have been further developments in this area with the recent
demonstration of two types of gallbladder adenocarcinoma, one being derived from
ordinary gallbladder epithelium and the other from metaplastic epithelium. Either
type may result from adenomata59.
Based on these findings gallbladder carcinomas have been divided into metaplas-
tic and non-metaplastic types according to the presence or absence of metaplastic
markers, such as endocrine cells and lysozyme immunoreactivity in the tumour
tissue. The metaplastic type is more commonly found in females and the survival
rates are better. The modes of tumour spread also differ, the metaplastic type
frequently showing lymphatic spread, whereas the non-metaplastic type usually
spread by direct invasion. This classification correlates well with biological behav-
iour and might reflect the histogenesis of gallbladder carcinoma6.
Adenomyomatosis of the gallbladder which is characterized by extensions of the
mucosa into and through a thickened muscular wall also has malignant potential
and 7 cases of gallbladder carcinoma arising in adenomyomatosis have been
described61. In contrast there is little evidence that inflammatory or cholesterol
polyps are even associated with malignant transformation49.
Diffuse calcification of the gallbladder Diffuse calcification of the gallbladder is
found in less than 0.1 percent of cholecystectomies and 95 percent of cases are
associated with gallstones5. "Porcelain gallbladder" so called because of the
characteristic blue discolouration and the brittle consistency of the gallbladder wall,
is five times more frequent in women and is associated with gallbladder carcinoma
in 10 to 25 percent of cases62.
Typhoid carriers Chronic typhoid carriers die of hepatobiliary cancer six times
more often than the matched controls. It has been suggested that a combination of
bile stasis (secondary to bile duct obstruction) and alteration of bile salts by
salmonella surviving in the gallbladder may be responsible63.
Xanthogranulomatous cholecystitis This granulomatous inflammation caused by
penetration of the gallbladder wall by bile lipids, is found in 0.7 to 1.8% of routine
cholecystectomy specimens64. Xanthogranulomatous cholecystitis is also present in
8.6% of gallbladder carcinomas and is of importance because of the difficulty in
differentiating the two conditions65. The occasional co-existence of these two
conditions can further complicate the diagnostic problem.
Occupation Specific substances in the working environment (e.g. 3,3 dichoro-
benzidine) directly or in combination with other chemicals have been shown to be
partly responsible for the development of carcinoma of the gallbladder, bile ducts
and liver. This is a particular problem amongst rubber workers5’ 66.
Chronic inflammatory bowel disease Inflammatory bowel disease is associated
with an increased risk of carcinoma of the biliary tree and in 13 percent of these
cases, the tumour originates in the gallbladder. The risk is highest in those with a
long history of colitis, especially if there is total involvement of the co|on67. In these
patients carcinoma occurs 10 to 15 years before the peak incidence in the general
population49.
Previous biliary surgery In several uncontrolled studies patients who have
undergone previous operations, particularly cholecystostomy, appear to have a282 J.A. PARASKEVOPOULOS ETAL.
higher incidence of gallbladder carcinoma. It is suggested that these tumours can
occur anywhere from 1.3 to 50 years after the original procedure49’68.
CLINICAL FEATURES
Carcinoma of the gallbladder, despite being the most common malignancy of the
biliary tract and the fifth most common gastrointestinal malignancy, because of its
nonspecific clinical signs and symptoms, is nearly always diagnosed at a late stage69.
The clinical picture initially may mimic benign gallbladder disease until there is
invasion or spread to adjacent organs. Even when spread has occurred, the mean
correct pre-operative rate of diagnosis is only about 10% (4.3 to
19%)3’
11,15, 23, 38, 45, 49.
In the review by Alborez-Saavedra and Henson the most common initial
complaint was pain in the right upper quadrant (75% of patients) which was
continuous or intermittent5. Jaundice due to obstruction of the common bile duct
or to liver metastases occurred in 30 to 60 percent of cases and was usually an
ominous sign, indicating nonresectability of lesions. Less common signs were
ascites (20%), duodenal obstruction (10%), palpable mass, hepatomegaly, anor-
exia, nausea, vomiting and weight loss5. These findings are similar to those
reported in the collective reviews of Piehler and of Vaittinen and Gupta’s review of
328 cases of primary carcinoma of the gallbladder from India3’ 32.49 (See Table 2). In
Vaittinen’s review of 3958 patients in 89 series, pain was present in 79% of patients
the duration of symptoms often being difficult to establish due to previous or
coexisting symptoms of biliary disease4. Whilst the duration of symptoms in this
series varies from a matter of hours to more than 40 years9’ 2’ 27’ 3a’ 32’ 37, the usual
time before presentation is between 3.5 and 5.5 months. Signs and symptoms
present at the resectable stage of gallbladder carcinoma are so similar to those of
non-malignant diseases of the organ that late diagnosis and a dismal 5 year survival
rate often results.
DIAGNOSTIC METHODS
Haematological and biochemical parameters are of almost no value in the investi-
gation of malignant gallbladder disease and it is essential if there is the slightest
suspicion to study gallbladder morphology. The investigations usually employed in
this respect are cholecystography, ultrasound examination (US), computed tomo-
graphy (CT) and angiography34.
Cholecystography is unreliable because filling of the gallbladder is very variable
with or without gallstonesTM. In contrast, US examination and computed tomogra-
phy seem to increase the likelihood of accurate pre-operative diagnosis and three
primary tumour patterns have recently been described; a mass replacing the
gallbladder in 40 to 65% of cases, local or diffuse thickening of the gallbladder wall
in 20 to 30% of cases and the least common form of gallbladder carcinoma (15 to
25% of cases) is an intraluminal mass7’ 72, 73. In the latter group carcinomas tend to
expand into the lumen of the gallbladder before invading the wall resulting in an
improved prognosis but of course also increased diagnostic difficulties. All these
investigations, however, frequently fail to differentiate gallbladder wall thickeningGALLBLADDER TUMOURS 283
due to inflammatory disease from that due to tumour (although in the latter the
wall is typically thicker and more irregular) and it is important in cases of polypoid
tumours over 5 mms in diameter or abnormal thickening of the gallbladder wall to
have a high index of suspicion71’73. Non-visualisation of the gallbladder by US or
computed tomography in patients with a mass in the right upper quadrant is also
said to be suggestive of gallbladder carcinoma73. In difficult cases the use of higher
frequency transducers, standoff pads (with redirection of scanning angle if the
anterior wall is obscured by reverberations) and decubitus, erect and prone views
(to distinguish sludge from a mass) are all said to improve the diagnosis of early
lesions74.
In a review of 67 patients by Tashiro, a correct diagnosis was made in 58.3% of
the patients examined by angiography and in his series it was the most useful
diagnostic measure to detect the disease at a resectable stage34. Coeliac or selective
hepatic angiography can be used to demonstrate malignancies of the gallbladder
when the disease is still localised to the gallbladder wall. In these cases enlarged
cystic or hepatic arteries, infiltration and cutoff of the cystic artery or its branches,
neovasculature of the cystic wall and irregular thickness of the gallblader wall in the
venous phase, are all important criteria of malignancy7. Very occasionally endo-
scopic retrograde cholangiopancreatography (ERCP) can also be useful showing an
irregular filling defect within the gallbladder or obstruction of the common hepatic
duct close to the hilus with a failure of the gallbladder to fill. Generally, however,
despite all these advances, correct, definite diagnoses are rarely made3.
TREATMENT OPTIONS
No treatment option has significantly altered the relentless and fatal course in the
majority of cases of carcinoma of the gallbladder, although a few long term
survivors have been reported. This is due not to the natural history of this cancer,
but to diagnostic problems (vide supra) that allow involvement of the liver and
porta hepatis by the time of operation. As a consequence it is often only possible to
perform biopsies and palliative bypass procedures. The various treatments (surgical
and non surgical) are shown in Table 3.
Table 3 Available treatment options
Modalities References
Surgical
a) Curative:
b) Palliative:
Non-Surgical
a) Radiotherapy
b) Chemotherapy
Cholecystectomy
Extended cholecystectomy
Radical surgery
Biopsy
Biliary-enteric bypass
Surgery + Radiotherapy
Surgery + Radiotherapy
+ Chemotherapy
(7, 77, 80)
(78, 79, 80)
(6,81)
(2)
(2)
(85, 86, 87)
(85)
(82,83)
(84)284 J.A. PARASKEVOPOULOS ETAL.
Before attempting critical analysis of any of the available treatments, it is
important to consider known prognostic factors. Of these the depth ot" invasion ot"
the gallbladder wall and histologie grade correlate well with survival7’75 and in a
recent review of 21 patients who lived 5 or more years, tumours were well
differentiated carcinoma in 10, moderately differentiated in four and mixed in six76.
It has also been shown that the papillary form of gallbladder carcinoma is
associated with a better patient survival than the nodular or infiltrative form. This is
probably because the papillary form is predominantly limited to the mucosa and
has a lower cellular malignancy than those tumours which extend to the muscularis,
subserosa and serosa (as evaluated by examination of nuclear DNA patterns in
cancer cells from these tumours)75.
Surgical Treatments It is generally accepted that simple classifications based on
staging, grading or a combination of these two factors can be applied to surgically
removed gallbladder carcinomas and produces useful information regarding pro-
gnosis. In more than 75% of cases, simple cholecystectomy is performed for
presumed benign disease but histological examination of the specimen shows
carcinoma. In a study of 32 patients with only mucosal or submucosal involvement
had a 63.6% five year survival and 45.5% 10 year survival77. In Nevin’s similar
series, 86% of patients having only intramucosal involvement lived more than five
years7, and it seems that patients with these Stage I and II carcinomas of the
gallbladder are usually cured by simple cholecystectomy. In contrast Stages III and
IV have a poor outlook although the prognosis may be improved by an extended or
radical cholecystectomy, with or without right hepatic lobectomy and adequate
nodal dissection. Stage V is so advanced at the time of diagnosis that surgical
treatment does not influence the outcome7. The various modes of spread of
gallbladder carcinoma have led some authors to believe that even with early stages
of the disease, simple cholecystectomy is an inadequate surgical practice.
Consequently it is often suggested that even in the incidentally found carcinoma, an
"adequate" operation must include cholecystectomy, wedge resection of the liver
with a margin of free tissue and adequate nodal dissection. For more advanced
disease with liver involvement some authors suggest that as well as cholecystectomy
a right or extended hepatic lobectomy, adequate nodal dissection including the
coeliac nodes and resection of neighbouring involved organs (whenever possible)
should be undertaken78’ 79. There is, however, no clear concensus on this point and
even recently it has been suggested that carcinomas of the gallbladder limited to the
mucosa can be treated only by cholecystectomy but for tumours involving the
subserosa or muscular layers, re-operation is advised (liver wedge resection and
nodal dissection) because of the increased incidence of lymphatic and liver
involvement amongst these patients8.
When carcinoma of the gallbladder spreads to the liver in a high percentage of
cases it does so in a localised rather than disseminated form, involves the
pericholedochal nodes (in the lesser omentum and behind the first part of the
duodenum) in 20% of cases, the various neighbouring organs and abdominal wall
in about 20% of cases and less commonly the extraheptic biliary ducts. A truly
curative supraradical approach would therefore have to include cholecystectomy,
adequate resection of the liver, meticulous dissection of the known areas of
lymphatic drainage and resection of the involved ducts and neighbouring organs or
abdominal wall6. Aggressive surgery for carcinoma of the gallbladder including an
extended right lobectomy or pancreaduodenectomy or extended lobectomy of theGALLBLADDER TUMOURS 285
liver combined with pancreatoduodenectomy or an extended right lobectomy
combined with portal resection has also been recently undertaken but further
follow up is obviously needed to assess the long term value of these procedures81.
Whether radical treatment is undertaken or not, however, patients with carcinomas
of the gallbladder can usually be offered palliative treatment and even when they
are jaundiced, biliary enteric bypass using the left hepatic ductal system (Segment 3
approached via the umbilical fissure) can be employed3.
Non surgical treatment Primary carcinoma of the gallbladder remains resectable
in only 25 percent of cases 1. Consequently, non-interventional treatments have
been investigated particularly external irradiation alone or in combination with
chemotherapy. A 20% response of gallbladder carcinoma to radiation therapy has
been reported in one series (900 rads per week with a total dose of 4,500 rads)82.
Other groups have not been so encouraged and in one series where 4,500 to 5,000
rads (in 180-200 rad fractions) was given, to the tumour and regional lymph nodes,
the outcome was very poor with deaths at 5.1/2, 6, 9 and 10 months from the date of
diagnosis83. While further evaluation of this mode of treatment is obviously needed
it seems very unlikely that used alone it will be of any but palliative value. The
situation is similar for combination chemotherapy. With fluorouracil, doxorubicin
and methotrexate, in one series there was a partial response in 4 out of 13 patients
(31%) with a median duration of 8.5 months84. In another similar study a 29%
partial response was also obtained with a four-drug combination of streptozocin,
semustine, fluorouracil and vincristine with 18% minor remission and an 11 month
median survival rate84. Thus while chemotherapy may produce temporary partial
remissions, there is no evidence to date of any long term survivors. There is also
recent limited experience regarding adjuvant postoperative external irradiation
with or without chemotherapy. It seems that radiotherapy may increase survival
where no curative surgery can be performed85’86’87, but there is no clear difference
in survival between patients and controls with regard to any regimens of chemoth-
erapy in this period85.
CONCLUSION
Primary carcinoma of the gallbladder is a rare malignancy with a dismal prognosis,
mainly due to its non-specific clinical symptoms and signs, and the lack of a reliable
diagnostic test. The result is almost invariably a delay before effective treatment,
which allows vital adjacent organs to become involved. Although ultrasound scans
and computerised tomography have a high resolution in biliary tract pathology,
they have not yet proved satisfactory in the pre-operative diagnosis of gallbladder
carcinoma. Selective hepatic angiography on the other hand has given encouraging
results in the differential diagnosis of gallbladder abnormalities but further evalu-
ation of this invasive technique is required. While initial experience suggests that
digital subtraction angiography may become a valuable tool in the pre-operative
assessment, to date, a high index of clinical suspicion remains the mainstay of early
diagnosis and a consequently better prognosis, although naturally a small number
of cases will be discovered incidentaly during ultrasound examinations.
In respect of "curative surgical management" evidence so far is generally in
favour of accepting simple cholecystectomy when the tumour is confined to the
mucosa but re-operating to do an extended or radical cholecystectomy when the286 J.A. PARASKEVOPOULOS ET AL.
tumour extends through the gallbladder wall but has not yet invaded the serosa; in
the latter situation, aggressive surgery (although advocated by a few enthusiasts)
does not confer reproducible or consistent improvements in quality of life or
survival.
The association of gallstones and primary carcinoma of the gallbladder has often
raised the question of prophylactic cholecystectomy. Mortality from gallbladder
carcinoma has declined markedly in England, Wales, Scotland, the United States
and Canada, but has risen by 1/2 in Sweden over the last 20 years. These findings
correlate with cholecystectomy rates88, and furthermore every 100 cholecystecto-
mies performed reduces the number of deaths from carcinoma of the gallbladder by
one. It is always worth remembering, however, that routine cholecystectomy in
patients with asymptomatic cholelithiasis which carries an associated morbidity and
mortality should be balanced against the risk of surgery and the general medical
condition of the patients.
These observations clearly leave one important question unanswered. What will
be the effect of gallstone treatments that leave an intact (and damaged?) gallblad-
der mucosa in situ for years after the treatment is finished? On this point, one can
only speculate but careful follow up of patients after extracorporeal shock wave
(lithotripsy) or percutaneous gallstone extraction is going to be essential (although
the development of carcinoma has been shown to be related to gallstone diameter).
Furthermore, these fears obviously make treatments which include ablation of the
mucosa increasingly attractive in terms of long term safety.
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